Domperidona [Inn-Spanish] en es it fr

Domperidona [Inn-Spanish] Brand names, Domperidona [Inn-Spanish] Analogs

Domperidona [Inn-Spanish] Brand Names Mixture

  • No information avaliable

Domperidona [Inn-Spanish] Chemical_Formula


Domperidona [Inn-Spanish] RX_link

No information avaliable

Domperidona [Inn-Spanish] fda sheet

Domperidona [Inn-Spanish] msds (material safety sheet)

Domperidona_[Inn-Spanish] MSDS

Domperidona [Inn-Spanish] Synthesis Reference

No information avaliable

Domperidona [Inn-Spanish] Molecular Weight

425.911 g/mol

Domperidona [Inn-Spanish] Melting Point

242.5 oC

Domperidona [Inn-Spanish] H2O Solubility

0.986 mg/L

Domperidona [Inn-Spanish] State


Domperidona [Inn-Spanish] LogP


Domperidona [Inn-Spanish] Dosage Forms


Domperidona [Inn-Spanish] Indication

For management of Dyspepsia, Heartburn, Epigastric pain, Nausea, Vomiting

Domperidona [Inn-Spanish] Pharmacology

Domperidone is indicated for treating symptoms associated with upper gastrointestinal motility disorders caused by chronic and subacute gastritis. It is a gastrointestinal emptying (delayed) adjunct, a peristaltic stimulant, and also exhibits antiemetic properties.

Domperidona [Inn-Spanish] Absorption


Domperidona [Inn-Spanish] side effects and Toxicity

Side effects include galactorrhea, gynecomastia, or menstrual irregularities.

Domperidona [Inn-Spanish] Patient Information

No information avaliable

Domperidona [Inn-Spanish] Organisms Affected

Humans and other mammals